13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001889830
Total reported value
$394.3M
$394.3M
13 檔
94.2%
At the close of Q3 2025, MIC Capital Management UK LLP disclosed equity holdings valued at approximately $394.3M, spread across 13 reported holdings.
In Q3 2025, MIC Capital Management UK LLP adopted a defensive or profit-taking posture, trimming 1 positions and completely liquidating 3 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HAYW | Hayward Holdings Inc | Stock-Other | 29.85% | +2.14% | -6.34% | |
| 2 | KLAR | Klarna Group plc | Stock-Other | 19.89% | -5.70% | — | |
| 3 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 9.41% | +0.58% | — | |
| 4 | CPNG | Coupang Inc | Stock-Consumer Disc | 9.09% | -1.35% | — | |
| 5 | GRAB | Grab Holdings Limited | Stock-Tech | 6.02% | -0.41% | — | |
| 6 | BABA | Alibaba Group Holding-sp Adr | Stock-Consumer Disc | 5.36% | +3.65% | NEW | |
| 7 | QSR | Restaurant Brands Intern | Stock-Consumer Disc | 4.95% | -1.00% | — | |
| 8 | META | Meta Platforms Inc-class A | Stock-Comm Services | 4.89% | -0.64% | — | |
| 9 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 4.75% | +3.30% | — | |
| 10 | MNDY | monday.com Ltd. | Stock-Tech | 2.55% | -0.08% | — | |
| 11 | NMRA | Neumora Therapeutics Inc | Stock-Other | 1.62% | -0.55% | — | |
| 12 | ACHR | Archer Aviation Inc-a | Stock-Industrials | 1.34% | -0.19% | — | |
| 13 | LYEL | Lyell Immunopharma Inc | Stock-Other | 0.28% | -0.19% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CPNG | Coupang Inc | +2.8% | — | Unchanged |
| 2 | HAYW | Hayward Holdings Inc | +1.5% | -6.34% | Trim |
| 3 | GRAB | Grab Holdings Limited | +1.4% | — | Unchanged |
| 4 | BABA | Alibaba Group Holding-sp Adr | +1.3% | — | Unchanged |
| 5 | RVMD | Revolution Medicines Inc | +1.1% | — | Unchanged |
| 6 | META | Meta Platforms Inc-class A | +1% | — | Unchanged |
| 7 | NMRA | Neumora Therapeutics Inc | +0.7% | — | Unchanged |
| 8 | ACHR | Archer Aviation Inc-a | +0.3% | — | Unchanged |
| 9 | QSR | Restaurant Brands Intern | -0.3% | — | Unchanged |
| 10 | MNDY | monday.com Ltd. | -0.7% | — | Unchanged |
| 11 | RXRX | Recursion Pharmaceuticals-a | -1% | — | Unchanged |
| 12 | ✓ | — | EXIT | Sold out | |
| 13 | KLAR | Klarna Group plc | — | NEW | New buy |
| 14 | SRAD | Sportradar Group AG | — | EXIT | Sold out |
| 15 | LYEL | Lyell Immunopharma Inc | — | NEW | New buy |
| 16 | LYEL | Lyell Immunopharma, Inc. | — | EXIT | Sold out |
According to official SEC Form 13F filings, MIC Capital Management UK LLP reported a total U.S. public equity portfolio value of $394.3M across 13 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including HAYW, KLAR, RXRX) accounted for 94.2% of total reported equity market value during Q3 2025.
Top New Position Initiated
KLAR
市值: $99.5M
Top Position Liquidated / Trimmed
前期市值: $123.6M
During Q3 2025, MIC Capital Management UK LLP's top holdings by market value included HAYW (29.9%)、KLAR (19.9%)、RXRX (9.4%). The largest single position, HAYW, represented 29.9% of total portfolio value.
In Q3 2025, MIC Capital Management UK LLP made 6 total portfolio adjustments, initiating 2 new buys, adding to 0 positions, trimming 1 holdings, and fully liquidating 3 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.